Thomas C. Badgett

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Tom C. Badgett, Thomas C Badgett, Thomas Badgett, Tom C Badgett, Tom Badgett
Publication record
29 papers · 2,177 citations · H-index 11

PAPERS

In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues
202227 citationsauthor #13
Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia
202216 citationsauthor #10
Novel methods to assess cell-free circulating tumor DNA in acute lymphoblastic leukemia.
20210 citationsauthor #5
Nanopore sequencing methods detect cell-free DNA associated with MRD and CNS infiltration in pediatric Acute Lymphoblastic Leukemia
20211 citationsauthor #9
CLO21-012: Isolation and Characterization of Circulating Tumor DNA to Monitor Acute Lymphoblastic Leukemia
20210 citationsauthor #4
Cell-Free DNA As a Biomarker for Acute Lymphoblastic Leukemia Relapse in the Central Nervous System
20201 citationsauthor #5
Informatics Methods and Infrastructure Needed to Study Factors Associated with High Incidence of Pediatric Brain and Central Nervous System Tumors in Kentucky.
20202 citationsauthor #6
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
201653 citationsauthor #4
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
2016101 citationsauthor #14
Utility of comprehensive genomic profiling (CGP) at an NCI-designated cancer center for identifying clinically relevant genomic alterations (CRGA) and implementing genomically directed therapy (GDT).
20161 citationsauthor #16
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis
20140 citationsauthor #4
Genomic Research Disclosure of Incidental Findings From Next-Generation Sequencing in Pediatric
20140 citationsauthor #1
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis
201483 citationsauthor #4
Abstract A21: Integrative genome and transcriptome sequencing defines the landscape of genetic alterations underlying pediatric rhabdomyosarcoma
20140 citationsauthor #10
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
2014628 citationsauthor #19
Disclosure of Incidental Findings From Next-Generation Sequencing in Pediatric Genomic Research
201381 citationsauthor #6
Abstract 2619: Whole genome and transcriptome sequencing identifies an activating mutation ofLPAR1in a patient with metastatic neuroblastoma.
20130 citationsauthor #10
LPAR1 (R163W) mutation promotes cell mobility through activation of Rho pathway.
20130 citationsauthor #10
Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma
201331 citationsauthor #10
Abstract 3161: Massively parallel transcriptome sequencing in neuroblastoma reveals specific mRNA splicing patterns controlled by RNA binding splicing factors.
20130 citationsauthor #2
The genetic landscape of high-risk neuroblastoma
20131,093 citationsauthor #44
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
201219 citationsauthor #5
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
20123 citationsauthor #5
Abstract 4833: A genomic portrait of tumor progression using next-generation sequencing
20110 citationsauthor #5
Abstract 4756: Exome sequencing of 81 neuroblastomas identifies a wide diversity of somatic mutation
20115 citationsauthor #13
Abstract 1137: Next generation sequencing of the neuroblastoma transcriptome identifies multiple protein disrupting mutations
20100 citationsauthor #1
Abstract 2212: A genomic portrait of tumor progression using next-generation sequencing
20100 citationsauthor #4
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma
200930 citationsauthor #8
New Technologies for Diagnosing Pediatric Tumors Expert Opinion on Medical Diagnostics.
20083 citationsauthor #2

TIMELINE

2008 3 citations

2009 30 citations

2010 0 citations

2011 5 citations

2012 22 citations

2013 1,205 citations

2014 711 citations

2016 155 citations

2020 3 citations

2021 1 citations

2022 43 citations

Thomas C. Badgett

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT